2009 Translational Advances in Radiation Oncology and Cancer Imaging
Click here to go to the previous page
Program Code:
010
Date:
Friday, September 11, 2009
SPEAKER(S):
Barry Rosenstein, Ph.D., Mount Sinai School of Medicine, New York, NY
Joseph Deasy, Professor,
Washington University School of Medicine
I am currently Professor and Director of the Division of Bioinformatics and Outcomes Research. I have collaborated or directed many studies of radiotherapy dose-volume effects, and their application in treatment planning. I am a member of the QUANTEC (quantitative assessment of normal tissue effects in the clinic) steering committee; QUANTEC and the IJROBP will be publishing a full journal update to dose-volume tolerance reviews this year. I Chair of the Bioinformatics Committee of the RTOG and past Chair of the Biological Effects Committee of the AAPM. I have an ongoing interest in bringing imaging, dosimetric, and biological/biomarker data together into models that predict toxicity risk.
|
Martin Hauer-Jensen, M.D., University of Arkansas